1. Home
  2. Detail

@thefonz21: Shawn the menace

fons
fons
Open In TikTok:
Region: PH
Thursday 01 December 2022 11:33:24 GMT
5874
173
7
5

Music

Download

No Watermark .mp4 (2.56MB) No Watermark(HD) .mp4 (4.66MB) Watermark .mp4 (0MB) Music .mp3

Comments

isabeggg
u don’t know me :
Seannnnnn HAHAHHAHHA
2022-12-01 14:53:07
0
logangster20
Meeby :
MY KINGGGGGG
2022-12-01 14:34:43
1
ultralord67
Blessing Webb :
😍😍😍
2022-12-01 14:32:47
0
stephmiraclecattery
stephmiraclecattery :
Seaan succkss HAHAHAH JK
2022-12-01 14:17:19
1
To see more videos from user @thefonz21, please go to the Tikwm homepage.

Other Videos
Daru band🥃🙌#punjabifamily❤️ #punjabihousecomedy😂
Daru band🥃🙌#punjabifamily❤️ #punjabihousecomedy😂


#fyp #foruyou #اكسبلورexplore تسمية.البنات علهاتق #تصميم_فيديوهات🎶🎤🎬 #شعب_الصيني_ماله_حل😂😂
#fyp #foruyou #اكسبلورexplore تسمية.البنات علهاتق #تصميم_فيديوهات🎶🎤🎬 #شعب_الصيني_ماله_حل😂😂
Hundreds of millions of people are predicted to be using weight loss medications globally over the next decade, which could lead to an uptick in productivity. The uptake in Australia has been slower than in the US. The active ingredient in most weight loss drugs — including Mounjaro, Wegovy and Ozempic — mimics a hormone called glucagon-like peptide-1 (GLP-1). That peptide slows digestion and sends fullness signals to the brain, resulting in people eating less. The growing popularity of GLP-1 medications is doing more than transforming waistlines. Adam Spielman, head of future health at Citigroup, co-authored a report looking at the reach of GLP-1 medications in the US and possible future commercial implications and is
Hundreds of millions of people are predicted to be using weight loss medications globally over the next decade, which could lead to an uptick in productivity. The uptake in Australia has been slower than in the US. The active ingredient in most weight loss drugs — including Mounjaro, Wegovy and Ozempic — mimics a hormone called glucagon-like peptide-1 (GLP-1). That peptide slows digestion and sends fullness signals to the brain, resulting in people eating less. The growing popularity of GLP-1 medications is doing more than transforming waistlines. Adam Spielman, head of future health at Citigroup, co-authored a report looking at the reach of GLP-1 medications in the US and possible future commercial implications and is "absolutely convinced" GLP-1 drugs will have "a really profound effect on the Australian economy", especially after 2031 when patents for the drugs end. He says the impact on the food industry would be uneven, with fruit and vegetable growers among those likely to benefit, while McDonald's or Burger King, could see the opposite. #ABCBusiness
❤️ #familiesoftiktok #fatherson #kidsbelike
❤️ #familiesoftiktok #fatherson #kidsbelike

About

Legal